Hackett G - Search Results

1

Commentary on "Late-onset hypogonadism - beyond testosterone".

Hackett G. Hackett G. Asian J Androl. 2015 Mar-Apr;17(2):334. doi: 10.4103/1008-682X.137679. Asian J Androl. 2015. PMID: 25248653 Free PMC article. No abstract available.

2

Testosterone replacement therapy: improved sexual desire and erectile function in men with type 2 diabetes following a 30-week randomized placebo-controlled study.

Hackett G, Cole N, Saghir A, Jones P, Strange RC, Ramachandran S. Hackett G, et al. Andrology. 2017 Sep;5(5):905-913. doi: 10.1111/andr.12399. Epub 2017 Aug 3. Andrology. 2017. PMID: 28771964 Free article. Clinical Trial.

3

Fundamental Concepts Regarding Testosterone Deficiency and Treatment: International Expert Consensus Resolutions.

Morgentaler A, Zitzmann M, Traish AM, Fox AW, Jones TH, Maggi M, Arver S, Aversa A, Chan JC, Dobs AS, Hackett GI, Hellstrom WJ, Lim P, Lunenfeld B, Mskhalaya G, Schulman CC, Torres LO. Morgentaler A, et al. Among authors: hackett gi. Mayo Clin Proc. 2016 Jul;91(7):881-96. doi: 10.1016/j.mayocp.2016.04.007. Epub 2016 Jun 21. Mayo Clin Proc. 2016. PMID: 27313122

4

Erectile dysfunction and testosterone deficiency as cardiovascular risk factors?

Hackett G, Kirby M. Hackett G, et al. Int J Clin Pract. 2018 Feb;72(2). doi: 10.1111/ijcp.13054. Epub 2018 Jan 30. Int J Clin Pract. 2018. PMID: 29381240

5

The response to testosterone undecanoate in men with type 2 diabetes is dependent on achieving threshold serum levels (the BLAST study).

Hackett G, Cole N, Bhartia M, Kennedy D, Raju J, Wilkinson P, Saghir A; Blast Study Group. Hackett G, et al. Int J Clin Pract. 2014 Feb;68(2):203-15. doi: 10.1111/ijcp.12235. Epub 2013 Dec 20. Int J Clin Pract. 2014. PMID: 24355040 Clinical Trial.

6

Important lessons about testosterone therapy- weight loss vs. testosterone therapy for symptom resolution, classical vs. functional hypogonadism, and shortterm vs. lifelong testosterone therapy.

Caliber M, Hackett G. Caliber M, et al. Among authors: hackett g. Aging Male. 2020 Dec;23(5):585-591. doi: 10.1080/13685538.2018.1549211. Epub 2019 Jan 16. Aging Male. 2020. PMID: 30651008

7

Testosterone replacement therapy: Pre-treatment sex hormone-binding globulin levels and age may identify clinical subgroups.

Ramachandran S, Hackett GI, Strange RC. Ramachandran S, et al. Andrology. 2020 Sep;8(5):1222-1232. doi: 10.1111/andr.12813. Epub 2020 Jun 1. Andrology. 2020. PMID: 32384175 Free article. Clinical Trial.

8

The association of sex hormone-binding globulin with mortality is mediated by age and testosterone in men with type 2 diabetes.

Ramachandran S, Strange RC, Fryer AA, Saad F, Hackett GI. Ramachandran S, et al. Among authors: hackett gi. Andrology. 2018 Nov;6(6):846-853. doi: 10.1111/andr.12520. Epub 2018 Jul 13. Andrology. 2018. PMID: 30006962 Free article.

9

Type 2 Diabetes and Testosterone Therapy.

Hackett G. Hackett G. World J Mens Health. 2019 Jan;37(1):31-44. doi: 10.5534/wjmh.180027. Epub 2018 Jul 17. World J Mens Health. 2019. PMID: 30079639 Free PMC article. Review.

10

PDE5 inhibitors in diabetic peripheral neuropathy.

Hackett G. Hackett G. Int J Clin Pract. 2006 Sep;60(9):1123-6. doi: 10.1111/j.1742-1241.2006.01087.x. Int J Clin Pract. 2006. PMID: 16939556

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

237 results

Search Page